Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair.
Implantation of cell-sheets into damaged regions of the heart after myocardial infarction (MI) has been shown to improve heart function. However, the tissue morphology following application of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has not been studied in detail at the leve...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4195599?pdf=render |
id |
doaj-e14ca96dfdc64ae2b89de3774014fd9c |
---|---|
record_format |
Article |
spelling |
doaj-e14ca96dfdc64ae2b89de3774014fd9c2020-11-25T01:19:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10729610.1371/journal.pone.0107296Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair.Dehua ChangZhili WenYuhua WangWenfeng CaiMashhood WaniChristian PaulTeruo OkanoRonald W MillardYigang WangImplantation of cell-sheets into damaged regions of the heart after myocardial infarction (MI) has been shown to improve heart function. However, the tissue morphology following application of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has not been studied in detail at the level afforded by electron microscopy. We hypothesized that increasing the number of CM derived from iPSC would increase the effectiveness of cell-sheets used to treat ischemic cardiomyopathy. We report here on the ultrastructural features after application of a bio-membrane 'cell patch'.iPSC-derived progenitor cells were transduced using lentivirus vectors with or without NCX1 promoter. iPSC-CM sheets were transplanted over the transmural MI region in a mouse model of regional ischemic cardiomyopathy. Mice were divided into four groups, 1) Sham; 2) MI; 3) MI + iPSC without NCX1 treated cells (MI + iPSCNull) and 4) MI + iPSC receiving NCX1 promoter treated cells (MI + iPSCNCX1). Echocardiography was performed 4 weeks after cell patch application, followed by histological and transmission electron microscopy (TEM) analysis.Large numbers of transplanted CM were observed with significant improvements in left ventricular performance and remodeling in group 4 as compared with group 3. No teratoma formation was detected in any of the treatment groups.Manipulation of iPSC yields large numbers of iPSC-CM and favorable morphological and ultrastructural tissue changes. These changes have the potential to enhance current methods used for restoration of cardiac function after MI.http://europepmc.org/articles/PMC4195599?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dehua Chang Zhili Wen Yuhua Wang Wenfeng Cai Mashhood Wani Christian Paul Teruo Okano Ronald W Millard Yigang Wang |
spellingShingle |
Dehua Chang Zhili Wen Yuhua Wang Wenfeng Cai Mashhood Wani Christian Paul Teruo Okano Ronald W Millard Yigang Wang Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. PLoS ONE |
author_facet |
Dehua Chang Zhili Wen Yuhua Wang Wenfeng Cai Mashhood Wani Christian Paul Teruo Okano Ronald W Millard Yigang Wang |
author_sort |
Dehua Chang |
title |
Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. |
title_short |
Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. |
title_full |
Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. |
title_fullStr |
Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. |
title_full_unstemmed |
Ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. |
title_sort |
ultrastructural features of ischemic tissue following application of a bio-membrane based progenitor cardiomyocyte patch for myocardial infarction repair. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Implantation of cell-sheets into damaged regions of the heart after myocardial infarction (MI) has been shown to improve heart function. However, the tissue morphology following application of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has not been studied in detail at the level afforded by electron microscopy. We hypothesized that increasing the number of CM derived from iPSC would increase the effectiveness of cell-sheets used to treat ischemic cardiomyopathy. We report here on the ultrastructural features after application of a bio-membrane 'cell patch'.iPSC-derived progenitor cells were transduced using lentivirus vectors with or without NCX1 promoter. iPSC-CM sheets were transplanted over the transmural MI region in a mouse model of regional ischemic cardiomyopathy. Mice were divided into four groups, 1) Sham; 2) MI; 3) MI + iPSC without NCX1 treated cells (MI + iPSCNull) and 4) MI + iPSC receiving NCX1 promoter treated cells (MI + iPSCNCX1). Echocardiography was performed 4 weeks after cell patch application, followed by histological and transmission electron microscopy (TEM) analysis.Large numbers of transplanted CM were observed with significant improvements in left ventricular performance and remodeling in group 4 as compared with group 3. No teratoma formation was detected in any of the treatment groups.Manipulation of iPSC yields large numbers of iPSC-CM and favorable morphological and ultrastructural tissue changes. These changes have the potential to enhance current methods used for restoration of cardiac function after MI. |
url |
http://europepmc.org/articles/PMC4195599?pdf=render |
work_keys_str_mv |
AT dehuachang ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT zhiliwen ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT yuhuawang ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT wenfengcai ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT mashhoodwani ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT christianpaul ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT teruookano ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT ronaldwmillard ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair AT yigangwang ultrastructuralfeaturesofischemictissuefollowingapplicationofabiomembranebasedprogenitorcardiomyocytepatchformyocardialinfarctionrepair |
_version_ |
1725137196088819712 |